For research use only. Not for therapeutic Use.
Metixene hydrochloride hydrate (Cat.No:I006165) is an anticholinergic medication used primarily for the treatment of Parkinson’s disease. It acts by blocking the action of acetylcholine, a neurotransmitter in the central nervous system. This helps to alleviate the symptoms associated with Parkinson’s disease, such as tremors and muscle stiffness.
| Catalog Number | I006165 |
| CAS Number | 7081-40-5 |
| Synonyms | Metixene hydrochloride hydrate |
| Molecular Formula | C20H26ClNOS |
| Purity | ≥95% |
| IUPAC Name | 1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine;hydrate;hydrochloride |
| InChI | InChI=1S/C20H23NS.ClH.H2O/c1-21-12-6-7-15(14-21)13-18-16-8-2-4-10-19(16)22-20-11-5-3-9-17(18)20;;/h2-5,8-11,15,18H,6-7,12-14H2,1H3;1H;1H2 |
| InChIKey | RAOHHYUBMJLHNC-UHFFFAOYSA-N |
| SMILES | CN1CCCC(C1)CC2C3=CC=CC=C3SC4=CC=CC=C24.O.Cl |
